ONELAB

Imspex are proud to be a part of the EU-funded ONELAB project. ONELAB focuses on designing and coordinating mobile laboratory operations for the detection and identification of infectious agents enabling enhanced situational awareness through integrated data communication that supports multi-agency decision-making and leadership See how the Breathspec® will be used in this project in both […]

PRESS RELEASE

PRESS RELEASE 9th August, 2022 Imspex Diagnostics announces BreathSpec® Instrument Receives CE Mark for Covid-19 testing Abercynon, Wales, UK – Imspex Diagnostics Ltd today announced that it has received CE mark for its BreathSpec® instrument for the detection of COVID-19 using non-invasive breath testing and analysis having met the requirements of the European In-Vitro Diagnostics […]

Respiratory Syncytial Virus (RSV) in Children

Respiratory Syncytial Virus or RSV is an illness found in children that can cause issues with breathing, it’s the most common cause of inflammation of the small airways in the lungs and pneumonia in babies.  What causes RSV? It’s caused when a child touches a contaminated surface and then touches their eyes, mouth or nose, […]

Investigating Group B Streptococcus transferred during birth

Group B Streptococcus or Strep is a type of bacteria that is actually more common than you think. It can be present in both men and women and can be found in the rectum or vagina. Although it is common, it is completely harmless with most patients not even realising that they have it. In […]

Breathspec registered trademark in the US

Imspex Medical is delighted to announce they have registered Breathspec as a trademark in the USA. Following a lengthy application process, the new trademark now gives our Breathspec product and technology more protection than before with the US market. How do you register a trademark in the USA? There are 4 main steps to registering […]

The Importance of Breathomics

In summary, Breathomics is the study of Volatile Organic Compounds (VOCs) in the human breath. Analysis of human breath can be used in clinical research to identify or explain physiological mechanisms or to diagnose respiratory conditions.  Exhaled breath samples or condensate samples are analysed using gas chromatography and mass spectrometry. These methods quantify VOCs in […]

Breath Analysis and VOCs for Infectious Disease Screening

In recent months, breath analysis has been receiving a high amount of attention in the healthcareworld because it provides a non-invasive clinical test with results being used for early diseasedetection. What is Breath Analysis? Your breath can highlight a lot of information if you know what to look for. Besides giving away thatyou may have […]

Imspex Diagnostics to Partner with Bond Digital Health

Imspex Diagnostics Ltd is delighted to have entered into a technology development and commercialisation partnership project with Bond Digital Health. Both businesses are Wales-based specialists in Life Sciences that will combine Imspex’s ‘early warning systems’ for healthcare using its market-leading gas chromatography (GC) and Ion Mobility Spectrometry (IMS) technology combined with Bond’s world’s first Transform® […]

BreathSpec’s Proven Accuracy on Breath Analysis

Healthcare providers globally are increasingly looking towards Breath Analysis as a potential new, non-invasive way of screening for and diagnosing health conditions. In current circumstances where respiratory conditions are prevalent, this need cannot be over-emphasised. Imspex’s BreathSpec® uses gas chromatography coupled with ion-mobility spectrometry (GC-IMS), combining the high discernment of chromatographic separation with highly specific […]

Talking about breath analysis on Radio Intereconomía

Santi Dominguez, Imspex’s CEO, spoke with Radio Intereconomía’s Gema González on the Visíon Global programme on 28 July 2021. Listen to their conversation about breath analysis as a rapid and non-invasive detection technology that is ideal for use at point-of-care with diseases including respiratory tract infections, COVID-19, lung cancer and Alzheimer’s disease. More details from […]

Pipeline Corner for Diagnostics at ECCMID 2021

It was a pleasure to be part of the speaker line-up at ECCMID 2021’s Pipeline Corner for Diagnostics on Saturday 10 July, along with speakers from Novel Microdevices, Fraunhofer UK Research, FluoretiQ Limited, Module and BioAmp Diagnostics.  This session was a fantastic opportunity to showcase breath analysis as an emerging strategy for detection and early […]

Breath analysis as a rapid diagnostic for respiratory tract infections

Patients with respiratory tract infections form a large part of general practitioners’ caseloads. In the absence of quick, convenient, accurate, and acceptable ways of identifying the agents causing these infections, GPs often find themselves at the centre of competing patient expectations, antimicrobial stewardship requirements and economic imperatives when prescribing interventions for these infections. This is […]